What's New

9/11 Exposure and Cancer Risk

This article provides an overview of cancer risk and health/financial support for first responders and civilians exposed to hazardous materials during and after the September 11, 2001 terrorist attacks in New York City, the Pentagon and Shanksville, PA.

Resources for More Information: Organizing Help

This article provides an overview of web based platforms for organizing help for practical challenges like meals, transportation and child care as well as communicating with support persons.

Encorafenib (Braftovi ™)

Encorafenib (Braftovi ™) is a kinase inhibitor used in the treatment of melanoma with a BRAF V600E or V600K mutation.

Binimetinib (Mektovi ®)

Binimetinib (Mektovi ®) is a kinase inhibitor used to treat melanoma with a BRAF V600E or V600K mutation.

Blogs

OncoLink's Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.


Demystifying Mindfulness: What Mindfulness Isn’t
by Christina Bach, MSW, LCSW, OSW-C
Jul 13, 2018


Cancer Goes To The Beach
by Christina Bach, MSW, LCSW, OSW-C
Jul 12, 2018


View all Blogs

Cancer Awareness

July Is UV Safety Month

It’s summertime - that means fun, sun and vacations! Just because you are going through cancer treatment doesn’t mean you can’t take a vacation. Watch the Cancer Goes to the Beach webinar to get tips and resources to plan a safe and stress free getaway. July is also UV Safety Month – learn all you need to know to stay sun safe this summer.

Need Cancer Patient Education Tools?

Our award winning cancer education content is now available for licensing and syndication.

I Wish U Knew!

I Wish U Knew is a video series featuring oncology professionals and survivors discussing what they wish patients and the public knew about cancer.